A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Lyell starts first head-to-head CAR-T therapy trial
Lyell starts first head-to-head CAR-T therapy trial
BridgeBio's dwarfism drug succeeds in Phase 3, adding to recent late-stage wins
BridgeBio's dwarfism drug succeeds in Phase 3, adding to recent late-stage wins
European VCs form coalition to get more support for biotech investing
European VCs form coalition to get more support for biotech investing
Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO
Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO
Hinge Health is looking to build AI tools for mental health support
Hinge Health is looking to build AI tools for mental health support
FDA may consider Moderna's flu vaccine in a narrower group
FDA may consider Moderna's flu vaccine in a narrower group
Former AstraZeneca senior staff charged with illegal trade in China
Former AstraZeneca senior staff charged with illegal trade in China
Prasad overruled vaccine review team, office director on Moderna flu shot
Prasad overruled vaccine review team, office director on Moderna flu shot
After CEO departs, CSL details profit crash, $1.1B impairment costs
After CEO departs, CSL details profit crash, $1.1B impairment costs
Madrigal pads MASH pipeline with six siRNAs from China's Ribo
Madrigal pads MASH pipeline with six siRNAs from China's Ribo
Gubra forms venture unit; Galecto's $275M offering
Gubra forms venture unit; Galecto's $275M offering
How a closet full of EKG machines illustrates pharma’s clinical trial cost problem
How a closet full of EKG machines illustrates pharma’s clinical trial cost problem
Oscar Health expects explosive growth for 2026, but it comes with a risk
Oscar Health expects explosive growth for 2026, but it comes with a risk
Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point?
Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point?
Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial
Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial
Moderna accuses FDA of shifting standard as agency refuses flu shot review
Moderna accuses FDA of shifting standard as agency refuses flu shot review
Isomorphic claims major advance with new AI drug design engine
Isomorphic claims major advance with new AI drug design engine
ILiAD raises $115M round to advance whooping cough vaccine
ILiAD raises $115M round to advance whooping cough vaccine
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page